-
-
Call more information
660-596-2224 -
DG Alerts The risk of greater COVID-19 severity and death is higher in people with any obese body mass index (BMI), according to a study published in the European Journal of Endocrinology. Matteo Rottoli, MD, Alma Mater Studiorum University of Bologna, Italy, and colleagues analysed the outcomes of 482 patients with COVID-19 hospitalised between March 1 and […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR), according to a late-breaking clinical science presentation at the TVT Connect 2020 virtual meeting. Susheel K. Kodali, MD, of NewYork-Presbyterian/Columbia University Irving Medical Center in New York City, […]
Read MoreThis is from a DEA Email alert we received and wanted to share with our readers. DEA is aware that registrants are receiving telephone calls and emails by criminals identifying themselves as DEA employees or other law enforcement personnel. In an attempt to create the illusion that these criminals are DEA employees, they have masked […]
Read MoreAuthor: Michael Walter Cardiovascular Business News When patients have stable ischemic heart disease (SIHD), two primary treatment options are revascularization followed by guideline-directed medical therapy (GDMT) or GDMT alone. How do patient outcomes change when revascularization is part of the equation? To address that very question, a team of researchers explored data from nearly 15,000 […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Low-risk transcatheter aortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery, according to a late-breaking clinical science presentation at the TVT Connect 2020 virtual meeting. In 2019, the Evolut Low Risk demonstrated similar outcomes for TAVR and surgical […]
Read More